What is EVGN's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.01B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for EVGN?

P/E (TTM) is n/a and 52-week range is $0.35 to $1.35 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s EVGN figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for EVGN?

The company profile lists revenue (TTM) near $2M, net income (TTM) near $-704M, EPS (TTM) near $-0.91 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Evogene Ltd based, and what identifiers does Chartloom list?

The company context section lists headquarters in Rehovot, Central(HaMerkaz), IL, 13.6M shares outstanding, ISIN IL0011050551 when available from company profile and filing metadata.

Evogene Ltd (EVGN) Stock Analysis, Quote & Company Profile

Please enable JavaScript to continue using this application.

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 142 full-time employees. The company went IPO on 2007-06-11. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

Employees

142

Website

evogene.com/

IPO

2007-06-11

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)